Pre-exposure Prophylaxis (PrEP) Use, Seroadaptation, and Sexual Behavior Among Men Who Have Sex with Men, San Francisco, 2004–2014

AIDS and Behavior

Volumn 20, Issue 12, 2016, Pages 2791-2797

  Chen, Yea Hung ^a   Snowden, Jonathan M ^b   McFarland, Willi ^a,c   Raymond, H Fisher ^a,c  

^a SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

MSM; Pre exposure prophylaxis; PrEP; Seroadaptation

Indexed keywords

ADOLESCENT; ADULT; CALIFORNIA; CONDOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MALE HOMOSEXUALITY; MIDDLE AGED; PRE-EXPOSURE PROPHYLAXIS; PREVENTION AND CONTROL; PROCEDURES; SEXUAL BEHAVIOR; SEXUALITY; STATISTICS AND NUMERICAL DATA; TRANSMISSION; UNSAFE SEX; UTILIZATION; UTILIZATION REVIEW; YOUNG ADULT;

ADOLESCENT; ADULT; CONDOMS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; PRE-EXPOSURE PROPHYLAXIS; SAN FRANCISCO; SEXUAL BEHAVIOR; SEXUAL PARTNERS; UNSAFE SEX; UTILIZATION REVIEW; YOUNG ADULT;

EID: 84961217976     PISSN: 10907165     EISSN: 15733254     Source Type: Journal    
DOI: 10.1007/s10461-016-1357-2     Document Type: Article

References (19)

1. Holmes D. FDA paves the way for pre-exposure HIV prophylaxis. Lancet. 2012;380(9839):325.
2. US Public Health Service (PHS) and Centers for Disease Control and Prevention (CDC), Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2014 Clinical Practice Guideline. 2014. http://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf. Accessed 4 Aug 2015.
3. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.
4. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.
5. Molina JM, Capitant C, Spire B, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46. doi:10.1056/NEJMoa1506273.
6. McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2015. doi:10.1016/S0140-6736(15)00056-2.
7. Eisingerich AB, Wheelock A, Gomez GB, et al. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS One. 2012;7(1):e28238.
8. Hosek SG, Siberry G, Bell M, et al. The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men. J Acquir Immune Defic Syndr. 2013;62(4):447–56.
9. Liu A, Cohen S, Follansbee S, et al. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014;11(3):e1001613.
10. Raymond HF, Chen YH, Ick T, et al. A new trend in the HIV epidemic among men who have sex with men, San Francisco, 2004–2011. J Acquir Immune Defic Syndr. 2013;62(5):584–9.
11. Snowden JM, Wei CY, McFarland W, et al. Prevalence, correlates and trends in seroadaptive behaviours among men who have sex with men from serial cross-sectional surveillance in San Francisco, 2004–2011. Sex Transm Infect. 2014;90:498–504.
12. Roberts, C. SF Records all time low in HIV infections, deaths. http://www.sfexaminer.com/sf-records-all-time-low-in-hiv-infections-deaths/. Accessed 4 Aug 2015.
13. San Francisco Department of Public Health. (2014). San Francisco sexually transmitted disease annual summary, 2014. https://www.sfdph.org/dph/files/reports/StudiesData/STD/SFSTDAnnlSum2014.pdf. Accessed 30 Dec 2015.
14. Marcus JL, Glidden DV, Mayer KH, et al. No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS One. 2013;8(12):e81997.
15. Grant RM, Anderson PL, McMahan V, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820–9. doi:10.1016/S1473-3099(14)70847-3.
16. Volk JE, Marcus JL, Phengrasamy T, et al. No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clin Infect Dis. 2015;61(10):1601–3. doi:10.1093/cid/civ778.
17. MacKellar D, Gallagher KM, Finlayson T, et al. Surveillance of HIV risk and prevention behaviors of men who have sex with men—a national application of venue based, time-space sampling. Public Health Rep. 2007;122(Suppl. 1):39–47.
18. Snowden J, Raymond HF, McFarland W. Prevalence of seroadaptive behaviors of men who have sex with men: San Francisco, 2004. Sex Transm Infect. 2009;13(4):677–81.
19. McFarland W, Chen YH, Raymond HF, et al. HIV seroadaptation among individuals, within sexual dyads, and by sexual episodes, men who have sex with men, San Francisco, 2008. AIDS Care. 2010;23(3):261–8.